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Hepatitis delta virus (HDV) is a single-stranded RNA virus that encodes two viral nucleocapsid proteins named small and large form
hepatitis delta antigen (S-HDAg and L-HDAg). The S-HDAg is essential for viral RNA replication while the L-HDAg is required for viral
assembly. In this study, we demonstrated that HDAg are acetylated proteins. Metabolic labeling with [3H]acetate revealed that both forms of
HDAg could be acetylated in vivo. The histone acetyltransferase (HAT) domain of cellular acetyltransferase p300 could acetylate the full-
length and the N-terminal 88 amino acids of S-HDAg in vitro. By mass spectrometric analysis of the modified protein, Lys-72 of S-HDAg
was identified as one of the acetylation sites. Substitution of Lys-72 to Arg caused the mutant S-HDAg to redistribute from the nucleus to the
cytoplasm. The mutant reduced viral RNA accumulation and resulted in the earlier appearance of L-HDAg. These results demonstrated that
HDAg is an acetylated protein and mutation of HDAg at Lys-72 modulates HDAg subcellular localization and may participate in viral RNA
nucleocytoplasmic shuttling and replication.
D 2003 Elsevier Inc. All rights reserved.Keywords: HDV; HDAg; Acetylation; p300; NLSIntroduction
Hepatitis delta virus (HDV) contains a 1.7-kb circular
RNA genome. It is a satellite virus that requires its helper
virus, hepatitis B virus (HBV), to supply the envelope
proteins for viral assembly (Bonino et al., 1984, 1986;
Rizzetto et al., 1980). However, HDV is capable of repli-
cating its genome in the absence of HBV (Kuo et al., 1989).
A double rolling-circle mechanism has been proposed for
HDV RNA replication (Branch and Robertson, 1984; Lai,
1995). Host cellular transcription machinery is believed to
be responsible for this process (Chang and Taylor, 2002;
Macnaughton et al., 2002; Modahl et al., 2000; Moraleda
and Taylor, 2001).0042-6822/$ - see front matter D 2003 Elsevier Inc. All rights reserved.
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E-mail address: peijer@ha.mc.ntu.edu.tw (P.-J. Chen).There are two viral proteins encoded by HDV named
large and small delta antigens (HDAg), respectively. These
two proteins are identical in sequence, except that the large
HDAg (L-HDAg) contains an additional 19 amino acids at
its C-terminus resulting from RNA editing of the termina-
tion codon (Bergmann and Gerin, 1986; Casey et al., 1992;
Jilbert et al., 1991). Although the similarity in amino acid
sequences, each protein has distinct functions. The small
HDAg (S-HDAg) is essential for HDV replication, while the
L-HDAg is necessary for virion assembly (Chang et al.,
1991; Taylor et al., 1991). Both HDAg have several
functional domains. A coiled-coil domain in the N-terminus
is responsible for HDAg oligomerization (Lazinski and
Taylor, 1993; Xia and Lai, 1992; Zuccola et al., 1998). A
nuclear localization signal (NLS) and an RNA-binding
domain in the middle portion of HDAg mediate the nuclear
import of HDV RNA (Chang et al., 1988; Chao et al., 1991;
Chou et al., 1998; Lin et al., 1990; Xia et al., 1992). The
additional 19 amino acid stretch of L-HDAg contains an
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Lai, 1993; Lee et al., 1994) and a sequence functioning as
nuclear export signal (Lee et al., 2001).
HDV replication takes place within the nucleus (Rizzetto
et al., 1977; Wu et al., 1992). A kinetic study of newly
synthesized HDV RNA discovered a transient phase of
shuttling viral genomic RNA into the cytoplasm and then
reimporting into the nucleus (Macnaughton and Lai, 2002).
A heterokaryon analysis also supported the point of HDV
RNA shuttling between the cytoplasm and the nucleus
(Tavanez et al., 2002). These results indicate that nucleocy-
toplasmic shuttling is important in the HDV life cycle.
However, the signal that regulates the shuttling of HDAg
and HDV RNA has not been identified. Posttranslational
modifications have been demonstrated to participate in
modulating functions and properties of several proteins
(Schwoebel and Moore, 2000; van der Geer, 2002). HDAg
had been identified to be a phosphorylated protein (Chang etFig. 1. Acetylation of HDAg in vivo. (Panel A) H7-SHDAg cells that stably expres
[3H]sodium acetate for 90 min. Extracts were subjected to immunoprecipitation w
by SDS-PAGE and autoradiography (see Materials and methods). (Panel B) S-HDA
transfection and the in vivo acetylation assay was performed as described in panel
that of the S-HDAg by 2-fold. (Panels C and D) One-thirtieth of extracts from radio
with an anti-HDAg polycloal antibody (see Materials and methods).al., 1988; Chen et al., 2002; Mu et al., 1999; Yeh et al.,
1996). Phosphorylation at serine residue 177 of HDAg
affects HDV viral replication (Mu et al., 2001) but does
not change the subcellular localization of HDAg (data not
shown). Another posttranslational modification that modu-
lates protein functions is acetylation. Several cellular tran-
scription factors have been shown to change their
nucleoplasmic localization when varying their status of
acetylation. For example, acetylation is crucial for nuclear
accumulation of HNF4 (hepatocyte nuclear factor-4) (Sou-
toglou et al., 2000) and MHC II (major histocompatibility
class II) trans-activator CIITA (Spilianakis et al., 2000). In
addition, reversible acetylation also controls the subcellular
localization of NF-nB (Chen et al., 2001).
In this study, we demonstrated that HDAg was acetylated
both in vivo and in vitro. An acetylation site of S-HDAg
was identified at Lys-72. A Lys to Arg substitution at this
site (K72R) resulted in reduction of HDV genomic RNAsed S-HDAg (lane 1) or the parental HuH-7 cells (lane 2) were labeled with
ith an anti-HDAg antibody and the immunopurified proteins were analyzed
g (lane 1) and L-HDAg (lane 2) were expressed in HuH-7 cells by transient
A. The exposure time of gel containing acetylated L-HDAg was longer than
labeled cells was subjected to SDS-PAGE followed by Western blot analysis
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HDAg and earlier appearance of L-HDAg. Thus, this study
suggests that HDAg is an acetylated protein and the acet-
ylation of HDAg may modulate its nucleoplasmic shuttling
as well as HDV life cycle.Fig. 2. Acetylation of S-HDAg in vitro by p300. (Panel A) Recombinant
proteins including full-length S-HDAg (FL, lanes 1 and 2), N-terminal S-
HDAg (NdAg, lanes 3 and 4), and C-terminal S-HDAg (CdAg, lanes 5 and
6) were incubated with (lanes 1,3,5) or without (lanes 2,4,6) recombinant
p300 HAT domain in acetylation reaction buffer containing [14C]-acetyl
CoA. The reaction products were separated by SDS-PAGE and sub-
sequently visualized by autoradiography (see Materials and methods).
(Panel B) Coomassie blue staining of the different fragments of
recombinant S-HDAg used as substrates in the acetylation reaction (see
Materials and methods).Results
Both HDAg are acetylated in vivo
We first examined whether HDAg could be acetylated in
vivo. S-HDAg-producing cells (H7-SHDAg) were used to
analyze acetylation of HDAg in metabolic labeling experi-
ments. H7-SHDAg cells and its parental HuH-7 cells were
incubated with [3H]acetate briefly and their lysates were
subsequently subjected to immunoprecipitation with an anti-
HDAg monoclonal antibody. As shown in Fig. 1, a [3H]-
labeled 24-kDa protein was specifically immunoprecipitated
from cell lysates of H7-SHDAg (Fig. 1A, lane 1). No such a
protein could be immunoprecipitated from the lysates of
parental HuH-7 cells (Fig. 1A, lane 2). This 24-kDa band
could also be recognized by a human anti-HDAg antibody
(Fig. 1C, lane 1). These results indicated that S-HDAg was
acetylated in vivo.
We also examined acetylation of L-HDAg and S-HDAg
by a transient transfection system. As shown in Fig. 1B, S-
HDAg expressed in HuH-7 cells was acetylated (Fig. 1B,
lane 1). Meanwhile, a [3H]-labeled 27-kDa protein could be
specifically detected in cells expressing L-HDAg (Fig. 1B,
lane 2). This 27-kDa protein was recognized by a human
anti-HDAg antibody by Western blotting analysis (Fig. 1D,
lane 2). These results indicated that L-HDAg was also
acetylated in vivo. It was noteworthy that the labeling
intensity of L-HDAg was weaker than that of S-HDAg
(Fig. 1B).
S-HDAg is acetylated in vitro by p300
There are several histone acetyltransferases (HAT) iden-
tified in human cells. These proteins, including p300/CBP,
PCAF, TAFII 250 etc., have been demonstrated to acetylate
histones as well as a wide spectrum of cellular and viral
factors. Therefore, we tested whether p300 was able to
acetylate S-HDAg. The recombinant protein corresponding
to the p300 HAT domain was expressed in E. coli. Its
enzymatic activity was verified by the [14C]acetyl coenzyme
A (acetyl CoA) exchange reaction with core histones H2A,
H2B, H3, and H4 as substrates (data not shown). As shown
in Fig. 2A, the in vitro acetylation experiment demonstrated
that recombinant full-length S-HDAg (FL) could be acety-
lated by the p300 HAT domain (Fig. 2A, lane 1).
To define the acetylated sites on HDAg, S-HDAg protein
variants harboring N-terminal 1–88 amino acids (NdAg)
and 89–195 amino acids (CdAg), respectively, were used as
substrates for in vitro acetylation assay. As shown in Fig.2A, the 15-kDa NdAg was acetylated by p300 HAT (Fig. 2A,
lane 3). On the other hand, no specific signal appeared when
using CdAg as the substrate (Fig. 2A, lanes 5 and 6).
Acetylation of these recombinant S-HDAg variants was
not detected in the absence of the p300 HAT protein,
indicating that acetylation of S-HDAg in this reaction was
specifically catalyzed by the p300 HAT (Fig. 2A, lanes 2, 4,
6). Taken together, these results suggest that p300 catalyzed
the acetylation of HDAg and the acetylated targets were
primarily located within the N-terminal 88 amino acid
residues.
A direct association between S-HDAg and p300
CBP/p300 acetylates and interacts with several structur-
ally unrelated cellular and viral factors (for reviews see
Chan and La Thangue, 2001; Goodman and Smolik, 2000).
In the current study, we had demonstrated that HDAg was
an acetylated protein and could be a substrate of p300. We
further tested the interaction between these two proteins. As
shown in Fig. 3, GST fusion proteins harboring N- or C-
terminal portions, but not the middle portion, of p300 could
pull down S-HDAg from cell extracts (Fig. 3A, lanes 2–5).
This result suggested that S-HDAg associated with p300
through its N- and C-terminal domains.
Fig. 3. Interaction of S-HDAg and p300. (Panel A) Cell lysates from H7-SHDAg cells were incubated with GST-p300 variants harboring the N-terminus (GST-
p300N, lane 3), middle portion (GST-p300M, lane 4), and C-terminus (GST-p300C, lane 5), or with GST only (lane 1). Bound S-HDAg was visualized by
Western blot analysis using anti-HDAg antisera (see Materials and methods). (Panel B) Various GST-p300 fusion proteins were detected by using anti-GST
antisera (Amersham Pharmacia Biotech). (Panel C) Schematic diagram of the GST-p300 and its various derivatives used for in vitro binding assay. Br,
bromodomain. CH1–3, cysteine–histidine-rich regions 1–3. KIX, CREB-binding domain.
J.-J. Mu et al. / Virology 319 (2004) 60–70 63Lys-72 on S-HDAg is acetylated by the p300
acetyltransferase
To identify the acetylation site(s) on HDAg, we per-
formed LC/MS/MS assay to analyze acetylated S-HDAg.
First, the recombinant S-HDAg was incubated with the HAT
domain of p300 and [14C]acetyl CoA and then subjected to
digestion by endopeptidase Glu-C. The digested peptides
were then analyzed by LC/MS/MS (Tsay et al., 2000; Wang
et al., 2003). One peptide, 64GAPPAKRARTDQME80, wasfound to be highly acetylated (data not shown). It is
consistent with our finding that acetylation target was
primarily in the N-terminal 88 residues (Fig. 2). This result
was further corroborated by the collision-induced dissocia-
tion (CID) experiment of this acetylated peptide. As shown
in Fig. 4, the presence of a parent ion with C2H2O neutral
loss (the 764.7-m/z ion) is a signature indicative of an
acetylated peptide. Furthermore, the masses of y7 to y12
ions as well as a4 to b7 deduce that Lys-72 is the acetylated
residue within.
Fig. 4. Acetylation of S-HDAg at Lys-72 by p300. After in vitro acetylation assay with full-length recombinant S-HDAg and p300 HAT domain, the reaction
products were digested by endoproteinase Glu-C. The resulting peptides were subjected to on-line HPLC/MS/MS. The fragment ions are denoted using the
nomenclature system described by Biemann (1988) and Roepstorff and Fohlman (1984). The average tandem mass spectrum of 785.8 m/z ion identified the
peptide and the site of acetylation as the sequence shown (see Materials and methods).
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To investigate the biological effects of acetylation on
HDAg, HDAg mutant with a substitution of Lys-72 to
Arg (K72R) was created by site-directed mutagenesis. We
first analyzed the subcellular localization of the K72RFig. 5. Subcellular localization of S-HDAg K72R mutant. HuH-7 cells were tra
expressing plasmids, respectively. One day posttransfection, cells were fixed and v
72 transfection were treated with leptomycin B (LMB) in the beginning of transfec
(panels A, C, E, and G) for the detection of S-HDAg or with the Hoechst dye fomutant. As shown in Fig. 5, the K72R mutant of S-
HDAg displayed a dramatic change in its subcellular
distribution pattern. While wild-type S-HDAg was pre-
dominantly in the nucleoli (Fig. 5A), the K72R mutant
was detected not only in the nucleolus but also in the
cytoplasm (Fig. 5C).nsfected with WT (panels A and B) or K72R (panels C to H) S-HDAg
isualized by confocal microscopy (Leica TCS SP2). Parallel samples of Lys-
tion (panels E–H). Cells were stained with anti-HDAg monoclonal antibody
r DNA staining (panels B, D, F, and H) (see Materials and methods).
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in the nucleus when expressed alone or in natural HDV
infection (Gowans et al., 1988; Huang et al., 2001; Mac-
naughton et al., 1990), the distinct distribution pattern of
K72R mutant might result from either impairing nuclear
transport, reducing nuclear retention, or accelerating nuclear
export, of it. To test these possibilities, cells transfected with
either wild-type or mutant S-HDAg were treated with
leptomycin B, an inhibitor for chromosome region mainte-
nance 1 (CRM1)-dependent nuclear export pathway, and
analyzed the subcellular localization of these S-HDAg. As
shown in Figs. 5E and 5G, the cytoplasmic accumulation of
K72R mutant was significantly decreased with treatment of
leptomycin B (Figs. 5E and 5G). In contrast, the nucleolus
and nuclear localization of wild-type S-HDAg were not
affected by leptomycin B treatment (data not shown). This
result suggested that the S-HDAg K72R mutant still pos-
sessed its nuclear targeting ability and the nuclear export of
S-HDAg was mediated in a CRM1-dependent pathway.Fig. 6. Functional assay of the S-HDAg K72R mutant. The wild-type dimer of
mutants, pCD2G72 and pCD2AG72 (indicated as 2G72, 2AG72), were transfected in
6, 9, and 12 posttransfection (indicated as D6, D9, D12) (see Materials and meth
RNA and antigenomic RNA were analyzed by Northern blotting and are shown i
2AGWT and 2AG72, antigenomic RNA and genomic RNA were also analyzed b
expression of both forms of HDAg from these dimer constructs was analyzed byReduction of genomic RNA accumulation by K72R mutation
S-HDAg is crucial for HDV replication. Because Lys-72
mutation resulted in a redistribution of S-HDAg from the
nucleus, where HDV replication takes place (Gowans et al.,
1988; Taylor et al., 1987), to the cytoplasm, we further
characterize the effect of this redistribution on HDV RNA
replication. A cDNA transfection system was used to
examine HDV replication (Wang et al., 1994). Plasmids
carrying cDNA dimer of the HDV genome with or without
K72R mutation were used in this transfection experiment.
As shown in Fig. 6A, the amount of genomic RNA (G
RNA) containing K72R mutation (2G72) was less (Fig. 6A,
lanes 4–6) than that of the wild-type (2GWT) (Fig. 6A, lanes
1–3) by 2–3-folds. Notably, the antigenomic RNA (AG
RNA) from the wild-type and K72R mutant showed similar
intensity (Fig. 6C, lanes 1–3 vs. lanes 4–6). Similar experi-
ments with plasmids carrying cDNA dimer of the wild-type
(2AGWT) or mutant (2AG72) HDV antigenome as the
319 (2004) 60–70 65HDV-pCD2G, pCD2AG (indicated as 2GWT, 2AGWT), and Lys-72 dimer
to HuH-7 cells, respectively. HDV RNA and HDAg were examined on days
ods). For detection of the RNA production from 2GWT and 2G72, genomic
n panels A and C, respectively. For detection of the RNA production from
y Northern blotting and are shown in panels B and D, respectively. The
Western blot and is shown in panels E and F.
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amount of antigenomic RNA was about equivalent for both
clones (Fig. 6B, lanes 1–3 vs. lanes 4–6). However, the
genomic RNA (G RNA) from the K72R mutant was
reduced by 4–5-folds when compared with that from the
wild-type (Fig. 6D, lanes 4–6). These results indicated that
K72R mutation on HDAg did not affect antigenomic RNA
accumulation, whereas it dramatically decreased the accu-
mulation of genomic RNA. Based on these findings, Lys72
of HDAg appeared to be crucial in the modulation of HDAg
functions on genomic RNA accumulation.
Earlier appearance of L-HDAg during K72R mutant
genome replication
L-HDAg appears in the late stage of HDV replication
through the process of RNA editing. In this study, we
noticed that L-HDAg with K72R mutation appeared
earlier as compared to that of the wild type. When using
the wild-type HDV genome cDNA (2GWT) in transfection
experiments, L-HDAg was detected at day 9 posttransfec-
tion (Figs. 6E and 6F, lane 2). Intriguingly, for HDV with
K72R mutation (2G72), the L-HDAg was detected earlier
at day 6 posttransfection (Figs. 6E and 6F, lane 4).
Furthermore, cells transfected with cDNA of the HDV
antigenome bearing K72R mutation (2AG72) also showed
similar earlier appearance of L-HDAg when compared
with cells transfected with wild-type antigenome cDNA
(2AGWT). These results suggested that the lack of acety-
lation at Lys-72 of HDAg favors earlier accumulation of
L-HDAg.Discussion
In this study, we have identified a previously unrecog-
nized posttranslational modification, acetylation, on HDAg
in vivo and in vitro. Lys-72 of S-HDAg was identified as the
acetylation site by LC/MS/MS. However, we cannot ex-
clude the possibility of the existence of other acetylation
sites. Furthermore, p300 HAT acetylated recombinant
HDAg in vitro (Fig. 2), suggesting that p300 is the enzyme
responsible for HDAg acetylation in vivo. CBP/p300 pro-
teins participate in many physiological processes. They
modulate functions of cellular and viral proteins by catalyz-
ing acetylation of these factors (for reviews see Chan and La
Thangue, 2001; Goodman and Smolik, 2000; Janknecht,
2002). Because there are several cellular acetyltransferases
in mammalian cells, further experiments to define the
acetyltransferase(s) responsible for HDAg acetylation in
vivo are still required.
HDAg interacted with p300 in vitro through the N-
terminal and C-terminal portions of p300 (Fig. 3). A wide
variety of cellular and viral proteins have also been identi-
fied to interact with CBP/p300 through these two regions
(for reviews see Chan and La Thangue, 2001; Goodman andSmolik, 2000; and the references therein). These regions
encompass the conserved CH1 and KIX domains in the N-
terminal and CH3 domain in the C-terminal portions of
CBP/p300 (Fig. 3C). Notably, several CBP/p300-associated
proteins, such as E1A, p53, and YY1, interact with more
than one of these different conserved domains.
The S-HDAg K72R mutant displayed a different subcel-
lular distribution pattern from that of the wild type (Fig. 5).
Notably, amino acids 68–88 of HDAg had been identified
as the bipartite NLS (Chang et al., 1992; Xia et al., 1992).
Acetylation of several cellular proteins had been demon-
strated to affect their nucleocytoplasmic shuttling abilities.
For example, nuclear accumulations of cellular factors
CIITA and HNF4 are increased when they are acetylated
at Lys residues in the NLS (Soutoglou et al., 2000; Spilia-
nakis et al., 2000). These results suggest that acetylation at
K72 of HDAg modulates its nuclear localization.
Treatment with leptomycin B led to the redistribution of
the majority of S-HDAg K72R mutant to the nucleoplasm
and nucleoli (Fig. 5). This result indicates that the CRM1-
dependent pathway is involved in the nuclear export of S-
HDAg, different from that of L-HDAg (Lee et al., 2001).
HDV genomic RNA is preferentially exported from the
nucleus after synthesis and processing in a CRM1-indepen-
dent pathway and L-HDAg is not essential for this export
process (Macnaughton and Lai, 2002). Our current result
suggests that the nuclear export of genomic RNA may
proceed without S-HDAg because they are in different
export pathways.
K72R mutant resulted in the reduction of HDV genomic
RNA accumulation and earlier appearance of L-HDAg in
the HDV life cycle (Fig. 6). Considering that HDAg is
essential for the import of HDV RNA to the nucleus, where
host RNA polymerase II produces the genomic RNA
(Macnaughton et al., 2002; Moraleda and Taylor, 2001),
the less accumulation of HDV genomic RNA is likely due
to the predominantly cytoplasmic distribution of the K72R
mutant. Furthermore, the poor nuclear retention of the S-
HDAg K72R mutant may also explain the earlier appear-
ance of L-HDAg because HDAg inhibits HDV RNA edit-
ing, which results in production of L-HDAg, occurring in
the nucleus (Polson et al., 1998; Wong and Lazinski, 2002).
This speculation is further supported by the finding that
introduction of adenosine deaminase (ADAR) to increase
HDV RNA editing also resulted in the earlier appearance of
L-HDAg and less accumulation of HDV genomic RNA
(Jayan and Casey, 2002).
Many proteins undergo posttranslational modifications
via well-defined mechanisms such as acetylation, phosphor-
ylation, and methylation. These modifications control a
spectrum of biochemical processes. Different modifications
of HDAg possibly generate synergistic or antagonistic
effects on the properties of HDAg and in turn dictate
modulation of HDV life cycle. Further studies are still
required to advance our understanding on the properties
and functions of HDAg in the HDV life cycle.
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Plasmid construction
pCD2G contains a tandem dimer of wild-type HDV
cDNA (1.7 kb XbaI fragment, genomic sense) with sequen-
ces derived from pSVLD3 (Kuo et al., 1989). This construct
transcribed HDV genomic RNA (G RNA) under the control
of CMV immediate–early promoter (pCMV-2) (Wang et al.,
1994). pCD2AG, like pCD2G, also contains the HDV cDNA
dimer but in a different orientation; therefore, pCD2AG
transcribed antigenomic HDV RNA (AG RNA) driven by
the CMV promoter. Both constructs could express both S-
HDAg and L-HDAg, and direct HDV RNA replication.
pCD2G72 and pCD2AG72 are similar to wild-type pCD2G
and pCD2AG but with a Lys to Arg mutation at Lys-72 in
HDAg ORF. pCDAg-S and pCDAg-L contained HDAg
ORF and expressed S-HDAg and L-HDAg, respectively
(Mu et al., 2001). For expressing recombinant full-length
S-HDAg, HDV cDNAs were amplified by PCR with the
BamHI site at the end of both primers (5V-GGATCCAAGCT-
TATGAGCCGGTCCGAGTCG-3V and 5V-GGATCCC-
TATGGAAATCCCTGGTTTC-3V). The PCR product was
digested with BamHI and subcloned into the BamHI-
digested vector pET-15a (Novagene). Plasmids for recombi-
nant protein expressing N-terminal 1–88 aa (NdAg) and C-
terminal 89–195 aa (CdAg) were gifts from Dr. H.N. Wu
(Huang and Wu, 1998).
Site-directed mutagenesis of S-HDAg
Site-directed mutagenesis was performed by Transformer
Site-Directed Mutagenesis Kit (Clontech, CA). The muta-
genic primers used in site-directed substitution of Lys-72 are
K72R, 5V-CCCCCGGCGAG¯GAGGGCCCG-3V (underlined
G is the mutated nucleotide). After synthesizing the second
strand by T4 DNA polymerase, plasmids containing unmu-
tated plasmids were removed by KpnI digestion. The DNA
isolated from pooled transformants was subjected to a
second round of KpnI digestion, and the second transfor-
mation was used to amplify and clone the mutated plasmids.
Every mutant clone was confirmed by sequence analysis.
The Lys-72 substituted mutant was designated K72R.
DNA transfection
For in vivo acetylation assay, DNA transfection was
performed by lipofectamine 2000 (Gibco BRL Life Tech-
nologies) according to the manufacturer’s instruction. Brief-
ly, 1 day before transfection, HuH-7 cells were seeded onto
a 60-mm diameter dish with 90% confluence in 10% FBS/
DMEM. For transfection, 40 Al of lipofectamine 2000 was
diluted into 0.5 ml opti-MEM (Gibco BRL Life Technolo-
gies) and incubated at room temperature for 5 min. Indicated
plasmids (10 Ag) were diluted into 0.5 ml opti-MEM. The
diluted DNA was then combined with diluted lipofectamine2000 and incubated at room temperature for 20 min. After
the culture medium was replaced by 0.5 ml of opti-MEM,
the DNA–liposome complexes were added to HuH-7 cells.
After a 6-h incubation, the medium was removed and
replaced by 10% FBS/DMEM. For indirect immunofluores-
cence, DNA transfection was performed by electroporation
(Electro Cell Manipulator ECM 600, BTX). HuH-7 cells
were trypsinized and washed with serum-free medium. Cells
(4  106) together with 20 Ag of DNA were suspended in
400 Al of serum-free medium and then loaded into a 4-mm
gap cuvette. After charging with 150 V for 70 ms (Desired
Field Strength is 375 V/cm), cells were plated onto four
coverslips (22  22 mm) in the presence of 10% FBS/
DMEM. For leptomycin B treatment, 2 ng/ml of LMB was
added in the medium while plating.
In vivo acetylation
HuH-7 cells were transfected with plasmids expressing
S-HDAg or L-HDAg. Forty-eight hours after transfection, 1
mCi/ml [3H]sodium acetate (TRK12, Amersham Pharmacia
Biotech, England) was added to metabolically label the
acetylated protein for 90 min. The cells were then lysed in
RIPA buffer and supernatants collected from 10 plates were
immunoprecipitated by the standard method as described in
detail elsewhere (Mu et al., 1999). The immunopurified
proteins were solubilized with SDS-PAGE sample buffer
and resolved on 12% SDS-polyacrylamide gels. Gels con-
taining [3H]acetate-labeled HDAg were fixed with 10%
glacial acetic acid and 45% methanol for 30 min and
enhanced with a commercial fluorography enhancing solu-
tion (Amplify, Amersham Pharmacia Biotech) for 30 min.
Gels were then dried and subjected to autoradiography at
70 jC for 14 days.
Western blot analysis
For the detection of immunoprecipitated HDAg’s in in
vivo acetylation assay, proteins were subjected to electro-
phoresis in a 12% SDS-polyacrylamide gel, followed by
Western blot procedure as described in detail elsewhere (Mu
et al., 1999). HDAg were detected by ECL Western blot
detection system (Amersham Pharmacia Biotech) with a
human polyclonal antibody against HDAg’s. For detection
of protein from whole cell lysates, 50 Ag of protein was
subjected to Western blot and detected with D9-3, a mono-
clonal antibody against HDAg (Mu et al., 1999).
Purification of recombinant p300 HAT and S-HDAg
For expression of recombinant p300 HAT domain (nt.
1195–1673), the pET-28c-p300 HAT at its native state was
expressed in E. coli BL21(DE3) and purified with the Ni-
NTA agarose column (Qiagen GmbH, Germany) according
to the manufacturer’s instructions. Briefly, cell pellets from
600-ml culture were lysed in 5 ml/g lysis buffer containing
J.-J. Mu et al. / Virology 319 (2004) 60–706850 mM NaH2PO4, pH 8.0, 300 mM NaCl, 10 mM imidaz-
ole, and 10 mM 2-mercaptoethanol. After sonication, lysates
were bound with Ni-NTA agarose and followed by washing
twice with three column volumes of wash buffer containing
50 mM NaH2PO4 pH 8.0, 300 mM NaCl, 20 mM imidazole,
and 10 mM 2-mercaptoethanol. Finally, the recombinant
protein was eluted with elution buffer containing 50 mM
NaH2PO4 pH 8.0, 300 mM NaCl, 250 mM imidazole, and
10 mM 2-mercaptoethanol. Fractions containing recombi-
nant proteins were stored at 70 jC.
For expression of recombinant S-HDAg in bacterial
system, full-length S-HDAg and CdAg-(89–195) in a
denatured form were expressed in Epicurian coli BL21-
CodonPlus (DE3)-RP (Stratagene) and affinity purified with
Ni-NTA agarose (Qiagen GmbH, Germany) according to
the manufacturer’s protocol. Briefly, cell pellets from 1000-
ml culture were lysed in 5 ml/g buffer B containing 8 M
urea, 100 mM NaH2PO4, and 10 mM Tris–HCl, pH 8.0.
After sonication, lysates were loaded onto the Ni-NTA
agarose column and followed by washing twice with four
column volumes of buffer C containing 8 M urea, 100 mM
NaH2PO4, and 10 mM Tris–HCl, pH 6.3. Finally, the
recombinant protein was eluted with elution buffer contain-
ing 8 M urea, 100 mM NaH2PO4, and 10 mM Tris–HCl, pH
5.9. Fractions containing recombinant proteins were dia-
lyzed in PBS and stored at 70 jC. The purified NdAg was
a gift from Dr. H. N. Wu (Huang and Wu, 1998).
In vitro acetylation assay
Purified recombinant p300 HAT was incubated with
purified His-S-HDAg for 60 min at 30 jC in a 40-Al reaction
l reaction buffer containing 50 mM Tris–HCl pH 8.0, 10%
glycerol, 0.1 mM EDTA, 1 mM DTT, and 0.2 ACi of
[14C]acetyl-CoA (CFA729, Amersham Pharmacia Biotech).
Proteins were then resolved by SDS-PAGE. Gels containing
[14C]acetyl-labeled recombinant S-HDAg were fixed with
10% glacial acetic acid and 45% methanol for 30 min and
enhanced with a commercial fluorography enhancing solu-
tion (Amplify, Amersham Pharmacia Biotech) for 30 min.
Gels were then dried and subjected to autoradiography at
70 jC for 1 day.
GST pull down assay
Three GST-p300 plasmids were constructed by fusing the
p300 open reading frame harboring amino acids 1–596 (N-
terminus), 744–1571 (middle), and 1572–2370 (C-termi-
nus) in-frame with the GST protein gene in pGEX-2TK
vector (Amersham Pharmacia Biotech). These three plas-
mids were gifts from Dr. David Livingston (Lee et al.,
1995). GST-p300 fusion proteins were expressed and puri-
fied according to manufacturer’s instruction. H7-SHDAg
cells, which stably express S-HDAg, were lysed in RIPA
buffer described above for 20 min. Cell lysates prepared
from H7-SHDAg cells were incubated for 2 h with variousGST-p300 fusion proteins coupled to GST-sepharose 4B
(Amersham Pharmacia Biotech). The beads were washed
with RIPA buffer three times and were eluted with Laemmli
sample buffer. Following Western blotting, S-HDAg was
detected by anti-HDAg monoclonal antibodies (D9-3) and
various p300 fusion proteins were detected by the anti-GST
antisera (Amersham Pharmacia Biotech).
Digestion of S-HDAg protein
The solution containing in vitro acetylated S-HDAg was
desalted and concentrated using a methanol–chloroform–
water precipitation method (Wessel and Flugge, 1984).
Briefly, to the solution, 4 volumes of methanol and 1
volume of chloroform were sequentially added. After addi-
tion with 3 volumes of water, the mixture was centrifuged at
10000  g for 15 min. The upper phase was removed and
three more volumes of methanol were added. The protein
was pelletted by centrifugation at 10000  g for 15 min.
The pellet was air dried and then resolubilized in 9 M urea.
The reaction was initiated by adding 25 mM of NH4HCO3
containing 50 ng of Glu-C (Promega). After a 5-h incubation
at 25 jC, the reaction was stopped by freezing at 20 jC.
Mass spectrometric analysis
Electrospray mass spectrometry was performed primarily
using the method described previously (Tsay et al., 2000;
Wang et al., 2003). Finnigan Mat LCQ ion trap mass
spectrometer interfaced with an ABI 140D HPLC (Perkin-
Elmer) was used. A 150  0.5 mm PE Brownlee C18
column (Perkin-Elmer) (5-mm particle diameter, 300-A˚ pore
size) with mobile phases of 0.1% formic acid in water
(solution A) and 0.1% formic acid in acetonitrile (solution
B) was used. The peptides were eluted at a flow rate of 5 Al/
min with an acetonitrile gradient, which consisted of 5–
20% solution B in 20 min and 20–65% solution B in 40
min. The spectra for the eluate were acquired as successive
sets of three scan modes, including MS scan, zoom scan,
and MS/MS scan. The MS scan determined the intensity of
the ions in the m/z range of 395–1605, the zoom scan
examined the charge number of the selected ion, and the
MS/MS scan acquired the CID spectrum (CID spectrum or
MS/MS spectrum) of the selected ion. In the first analysis,
the most abundant ion in an MS spectrum was selected for
the latter scans; in the second analysis, only the ions with m/
z values corresponding to the potential acetylated peptides
were selected for the CID experiment.
The acquired CID spectra were initially interpreted using
the SEQUEST Browser (Finnigan, USA), which automati-
cally correlated the MS/MS spectrum with the amino acid
sequence of S-HDAg protein. No enzyme was specified
during the sequence search, which could increase the
confidence of identification when matched peptides had
cleavage sites at Glu or Asp. A 44-Da tag, the mass of
[14C] acetyl group, was optionally added at Lys residue for
J.-J. Mu et al. / Virology 319 (2004) 60–70 69identification of the acetylated residues. Those MS/MS
scans that matched with the peptide sequences with appro-
priate cleavage sites were considered significant and were
also subjected to manual evaluation to confirm the
SEQUEST results. Specific ion chromatograms were plotted
using the in-house software.
Indirect immunofluorescence
HuH-7 cells that transiently expressed WT or K72R S-
HDAg were grown on rat tail-coated coverslips and fixed by
3.7% paraformaldehyde for 20 min at room temperature.
After extracting with CSK buffer (50 mM NaCl, 300 mM
sucrose, 10 mM Pipes pH 6.8, 3 mM MgCl2, 0.5% Triton
X-100) for 5 min, cells were blocked in PBS containing 1%
BSA, 10% goat serum, and 50 mM NH4Cl for 1 h at room
temperature. Cells were immunostained with anti-HDAg
monoclonal antibody, D9-3, for 1 h at room temperature
followed by incubating with FITC-conjugated anti-mouse
secondary antibody (Jackson) for another 1 h. The cover-
slips were mounted on a glass slide with a Vectashield
(Vector Laboratory, Inc., Burlingame, CA) and observed in
a confocal laser scanning microscope (Leica TCS SP2).
Northern blot analysis
Total RNAs were isolated from transfected HuH-7 cells
using the RNAzolB solution following the procedure de-
scribed by the manufacturer (Tel-Test, Inc). Transfected cells
were washed with cold PBS twice and lysed with 1 ml
RNAzolB solution/60 mm dish. After adding 0.2 ml of
chloroform and incubating on ice for 15 min, the lysate
was centrifuged at 12000 rpm for 20 min at 4 jC. The RNA
was in the aqueous phase and precipitated by adding equal
volumes of isopropanol. Northern blotting for the detection
of HDV RNAwas resolved by electrophoresis following the
glyoxal–dimethyl sulfoxide (DMSO) method (McMaster
and Carmichael, 1977). Total RNA (10 Ag) was mixed with
20 Al glyoxal solution and electrophoresed at 100 V for
about 2 h. The gel was then electrotransferred to a membrane
(Nytran, Schleicher and Schuell, Germany) with 0.25 TAE
(Tris–acetate/EDTA, 10 mM Tris–acetate, 0.25 mM EDTA)
at 90 V for 1.5 h. The membrane was then cross-linked and
hybridized with strand-specific riboprobes (synthesized by
in vitro transcription) (Mu et al., 1999).Acknowledgments
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